Armistice Capital’s Labcorp LH Stock Holding History

Armistice Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-911	Closed	-$229K	–	380
2025 Q4	$229K	Buy	+911	New	+$242K	﹤0.01%	331
2024 Q2	–	Sell	-1,890	Closed	-$413K	–	329
2024 Q1	$413K	Buy	+1,890	New	+$416K	0.01%	214

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Armistice Capital's LH Position: Q1 2026 in Review

Armistice Capital sold out of Labcorp (LH) in Q1 2026, closing a stake of 911 shares — an estimated $229K sold.

Armistice Capital first reported a position in LH in Q1 2024 and held it in 2 quarters. The position peaked at $413K in Q1 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Armistice Capital reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Armistice Capital sold 911 Labcorp shares in Q1 2026, an estimated $229K.
Armistice Capital first reported a position in Labcorp in Q1 2024 and held it in 2 quarters.
Armistice Capital's Labcorp position peaked at $413K in Q1 2024.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.